AI-generated summary
The authors studied diabetic rats with a controlled muscle injury, treating them with photobiomodulation (830 nm light), topical diclofenac, or both. They report that light alone or light combined with diclofenac reduced inflammatory markers (COX-2 gene expression and prostaglandin E2) and improved gait in the acute phase, while diclofenac alone reduced only COX-2 compared with untreated injury. The study was conducted in animals.
- Who or what was studied
- Diabetic rats with induced anterior tibialis muscle injury
- Wavelengths
- 830 nm
- Limits stated in the abstract
- The study was conducted in rats and assessed only the acute phase of muscle injury.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on link.springer.com.
Record from PubMed, a service of the National Library of Medicine.
Light parameters mentioned
Found in the title and abstract by pattern. They may be incomplete, so check the paper before comparing studies.
- Wavelength
- 830 nm
- Energy density (fluence)
- 107.1 J/cm2
- Power
- 100 mW
- Total energy
- 3 J
How to read a single study: what to check before relying on this kind of research.
Terms in this paper: Photobiomodulation therapy, Low-level laser therapy, Photobiomodulation, Power output, Laser. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.